\-\ Texto\\:\\ \ \(0\)\
\-\ muscle\\ weakness\\ in\\ right\\ upper\\ and\\ lower\\ extremities\ \(0\)\
\-\ acute\\ stroke\\ protocol\ \(0\)\
\-\ there\\ is\\ dilatation\\ of\\ the\\ ventricular\\ system\\ with\\ a\\ fat\\/csf\\ level\\ in\\ the\\ anterior\\ horns\\ of\\ the\\ left\\ and\\ right\\ lateral\\ ventricles\\.\\ \\ in\\ the\\ suprasellar\\ region\\ to\\ the\\ left\\ of\\ midline\\ is\\ a\\ 1\\.6\\ x\\ 1\\.7\\ cm\\ somewhat\\ rounded\\ lesion\\ measuring\\ fat\\ attenuation\\.\\ there\\ are\\ multiple\\,\\ rounded\\,\\ sub\\ centimeter\\ regions\\ of\\ fat\\ attenuation\\ material\\ scattered\\ throughout\\ the\\ extra\\ axial\\ space\\.\\ \\ there\\ is\\ no\\ evidence\\ of\\ intracranial\\ hemorrhage\\ or\\ edema\\.\\ prior\\ left\\ temporal\\ craniotomy\\ site\\ is\\ identified\\.\\ the\\ visualized\\ paranasal\\ sinuses\\ are\\ clear\\.\ \(0\)\
\-\ ruptured\\ dermoid\\ tumor\\ \\(inclusion\\ cyst\\)\\ of\\ cns\\;\\ possible\\ developing\\ acute\\ stroke\\ too\\ early\\ for\\ ct\\ diagnosis\ \(0\)\
\-\ ruptured\\ dermoid\\ cyst\\;\\ dermoid\\ cyst\\;\\ lipoma\\;\\ chronic\\ findings\\ with\\ above\\ differential\\ now\\ with\\ superimposed\\ acute\\ stroke\\ to\\ early\\ for\\ ct\\ detection\ \(0\)\
\-\ acute\\ onset\\ of\\ right\\ sided\\ hemiparesis\\.\ \(0\)\
\-\ when\\ evaluating\\ patients\\ seen\\ in\\ the\\ emergency\\ room\\ setting\\,\\ chronic\\ pathology\\ can\\ often\\ obscure\\ the\\ acute\\ clinical\\ problem\\.\\ \\ in\\ this\\ case\\ the\\ patient\\ had\\ clinical\\ symptoms\\ consistent\\ with\\ acute\\ stroke\\.\\ \\ although\\ acute\\/subacute\\ rupture\\ of\\ a\\ dermoid\\ can\\ be\\ symptomatic\\,\\ comparison\\ with\\ prior\\ films\\ in\\ this\\ case\\ demonstrated\\ stable\\ chronic\\ findings\\.\\ \\ this\\ allowed\\ the\\ er\\ physician\\ to\\ treat\\ the\\ patient\\ appropriately\\ for\\ the\\ acute\\ problem\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stroke\\:\\ 0\\.08070243614980827\ \(0\)\
\-\ dermoid\\:\\ 0\\.07050746602965383\ \(0\)\
\-\ acute\\:\\ 0\\.06682875703052248\ \(0\)\
\-\ problem\\:\\ 0\\.042284015362669375\ \(0\)\
\-\ ruptured\\:\\ 0\\.040235932773750926\ \(0\)\
\-\ fat\\/csf\\:\\ 0\\.03988922363785746\ \(0\)\
\-\ rounded\\:\\ 0\\.03810269898622993\ \(0\)\
\-\ acute\\/subacute\\:\\ 0\\.03675281105613825\ \(0\)\
\-\ \\;\\:\\ 0\\.036659207030816175\ \(0\)\
\-\ chronic\\:\\ 0\\.03267406741502715\ \(0\)\
\-\ cyst\\:\\ 0\\.031172458860082842\ \(0\)\
\-\ attenuation\\:\\ 0\\.031091593397520715\ \(0\)\
\-\ obscure\\:\\ 0\\.02947028656548621\ \(0\)\
\-\ sub\\:\\ 0\\.02903901878356619\ \(0\)\
\-\ early\\:\\ 0\\.028281981625723422\ \(0\)\
\-\ centimeter\\:\\ 0\\.027343573310980623\ \(0\)\
\-\ paranasal\\:\\ 0\\.026333873983767003\ \(0\)\
\-\ allowed\\:\\ 0\\.026333873983767003\ \(0\)\
\-\ superimposed\\:\\ 0\\.02481137517552622\ \(0\)\
\-\ horns\\:\\ 0\\.024350819997653178\ \(0\)\
\-\ 1\\.7\\:\\ 0\\.024350819997653178\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.02420716072926141\ \(0\)\
\-\ extra\\:\\ 0\\.02420716072926141\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.024067922454751214\ \(0\)\
\-\ appropriately\\:\\ 0\\.024067922454751214\ \(0\)\
\-\ inclusion\\:\\ 0\\.023801675848312602\ \(0\)\
\-\ clinical\\:\\ 0\\.02379465882412674\ \(0\)\
\-\ fat\\:\\ 0\\.02351956853286546\ \(0\)\
\-\ craniotomy\\:\\ 0\\.023197461402047793\ \(0\)\
\-\ detection\\:\\ 0\\.022467741277178464\ \(0\)\
\-\ treat\\:\\ 0\\.02183952206969332\ \(0\)\
\-\ too\\:\\ 0\\.02167496259380701\ \(0\)\
\-\ evaluating\\:\\ 0\\.021516178341267327\ \(0\)\
\-\ suprasellar\\:\\ 0\\.0210707481475422\ \(0\)\
\-\ protocol\\:\\ 0\\.020796428591811727\ \(0\)\
\-\ developing\\:\\ 0\\.02023399548467337\ \(0\)\
\-\ comparison\\:\\ 0\\.020117966386875463\ \(0\)\
\-\ sinuses\\:\\ 0\\.01989446975642489\ \(0\)\
\-\ prior\\:\\ 0\\.019856224182826822\ \(0\)\
\-\ cns\\:\\ 0\\.01978672926459811\ \(0\)\
\-\ setting\\:\\ 0\\.019528093907856262\ \(0\)\
\-\ somewhat\\:\\ 0\\.019006325371607416\ \(0\)\
\-\ physician\\:\\ 0\\.018226365073232817\ \(0\)\
\-\ ventricles\\:\\ 0\\.01818881392927492\ \(0\)\
\-\ lipoma\\:\\ 0\\.01807799483421476\ \(0\)\
\-\ scattered\\:\\ 0\\.01800559509961548\ \(0\)\
\-\ regions\\:\\ 0\\.017693410160760495\ \(0\)\
\-\ can\\:\\ 0\\.01754047377800063\ \(0\)\
\-\ ventricular\\:\\ 0\\.01727740339458092\ \(0\)\
\-\ material\\:\\ 0\\.01727740339458092\ \(0\)\
\-\ there\\:\\ 0\\.017263107101334687\ \(0\)\
\-\ case\\:\\ 0\\.016918592152644987\ \(0\)\
\-\ room\\:\\ 0\\.01662377768083185\ \(0\)\
\-\ dilatation\\:\\ 0\\.016571162124292847\ \(0\)\
\-\ findings\\:\\ 0\\.016460062767329954\ \(0\)\
\-\ rupture\\:\\ 0\\.01641688967477712\ \(0\)\
\-\ intracranial\\:\\ 0\\.01634168206737422\ \(0\)\
\-\ site\\:\\ 0\\.01634168206737422\ \(0\)\
\-\ films\\:\\ 0\\.01596041354421703\ \(0\)\
\-\ stable\\:\\ 0\\.015937618096117677\ \(0\)\
\-\ pathology\\:\\ 0\\.01582533226299675\ \(0\)\
\-\ visualized\\:\\ 0\\.015651276693640206\ \(0\)\
\-\ temporal\\:\\ 0\\.015483669129475734\ \(0\)\
\-\ measuring\\:\\ 0\\.01546314806537894\ \(0\)\
\-\ symptomatic\\:\\ 0\\.01536191594884259\ \(0\)\
\-\ system\\:\\ 0\\.01522389126878189\ \(0\)\
\-\ extremities\\:\\ 0\\.015166002800637506\ \(0\)\
\-\ midline\\:\\ 0\\.014959864648590594\ \(0\)\
\-\ er\\:\\ 0\\.014833412474877657\ \(0\)\
\-\ emergency\\:\\ 0\\.014641577366426588\ \(0\)\
\-\ throughout\\:\\ 0\\.014473969802262112\ \(0\)\
\-\ weakness\\:\\ 0\\.014360232366644275\ \(0\)\
\-\ clear\\:\\ 0\\.014296500511975773\ \(0\)\
\-\ sided\\:\\ 0\\.014296500511975773\ \(0\)\
\-\ above\\:\\ 0\\.014171668129537632\ \(0\)\
\-\ muscle\\:\\ 0\\.013888304223648621\ \(0\)\
\-\ identified\\:\\ 0\\.013816592946544443\ \(0\)\
\-\ now\\:\\ 0\\.013217717600459944\ \(0\)\
\-\ although\\:\\ 0\\.013058503532020833\ \(0\)\
\-\ this\\:\\ 0\\.013047111492952032\ \(0\)\
\-\ possible\\:\\ 0\\.013022543976851006\ \(0\)\
\-\ left\\:\\ 0\\.012978804560265811\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.012869939294914189\ \(0\)\
\-\ space\\:\\ 0\\.012789850710754004\ \(0\)\
\-\ x\\:\\ 0\\.012755956268540623\ \(0\)\
\-\ often\\:\\ 0\\.012336984382441867\ \(0\)\
\-\ differential\\:\\ 0\\.01227583633191371\ \(0\)\
\-\ right\\:\\ 0\\.012239344467562217\ \(0\)\
\-\ onset\\:\\ 0\\.012205525909163576\ \(0\)\
\-\ in\\:\\ 0\\.01144064878208837\ \(0\)\
\-\ demonstrated\\:\\ 0\\.011345791775823382\ \(0\)\
\-\ level\\:\\ 0\\.0111442942427463\ \(0\)\
\-\ when\\:\\ 0\\.011073897002787356\ \(0\)\
\-\ axial\\:\\ 0\\.011035255547818423\ \(0\)\
\-\ edema\\:\\ 0\\.01093630538204204\ \(0\)\
\-\ region\\:\\ 0\\.010921272521444854\ \(0\)\
\-\ ct\\:\\ 0\\.010817227632507177\ \(0\)\
\-\ are\\:\\ 0\\.01054184500026789\ \(0\)\
\-\ cm\\:\\ 0\\.01037084216206781\ \(0\)\
\-\ is\\:\\ 0\\.010177208658547071\ \(0\)\
\-\ evidence\\:\\ 0\\.010137749246003972\ \(0\)\
\-\ patients\\:\\ 0\\.010007124884009167\ \(0\)\
\-\ anterior\\:\\ 0\\.00995833856906216\ \(0\)\
\-\ for\\:\\ 0\\.009897395682932785\ \(0\)\
\-\ symptoms\\:\\ 0\\.009636459171484793\ \(0\)\
\-\ consistent\\:\\ 0\\.00948098764177015\ \(0\)\
\-\ upper\\:\\ 0\\.009330681019767957\ \(0\)\
\-\ tumor\\:\\ 0\\.009014625799143944\ \(0\)\
\-\ diagnosis\\:\\ 0\\.00887882050126887\ \(0\)\
\-\ lower\\:\\ 0\\.008696208458660013\ \(0\)\
\-\ lateral\\:\\ 0\\.008355964007350907\ \(0\)\
\-\ had\\:\\ 0\\.008343211851767911\ \(0\)\
\-\ multiple\\:\\ 0\\.008143918567779499\ \(0\)\
\-\ the\\:\\ 0\\.008132310864919164\ \(0\)\
\-\ lesion\\:\\ 0\\.007875815502264502\ \(0\)\
\-\ patient\\:\\ 0\\.007751963175713919\ \(0\)\
\-\ seen\\:\\ 0\\.0076408489369578746\ \(0\)\
\-\ be\\:\\ 0\\.005962700105628639\ \(0\)\
\-\ to\\:\\ 0\\.005797304639497551\ \(0\)\
\-\ a\\:\\ 0\\.0053837077169945876\ \(0\)\
\-\ \\,\\:\\ 0\\.004899729692620586\ \(0\)\
\-\ or\\:\\ 0\\.004531777144632161\ \(0\)\
\-\ of\\:\\ 0\\.004217332155583292\ \(0\)\
\-\ no\\:\\ 0\\.0038934124466235387\ \(0\)\
\-\ \\(\\:\\ 0\\.003268605096126066\ \(0\)\
\-\ \\)\\:\\ 0\\.0032286773398792087\ \(0\)\
\-\ with\\:\\ 0\\.002647153305201125\ \(0\)\
\-\ \\.\\:\\ 0\\.0017669452356145203\ \(0\)\
\-\ and\\:\\ 0\\.0016290407758571808\ \(0\)\
